...
首页> 外文期刊>American Journal of Ophthalmology Case Reports >Anterior migration of intravitreal fluocinolone acetonide (Iluvien?) implant in a pseudophakic eye with intact posterior capsule
【24h】

Anterior migration of intravitreal fluocinolone acetonide (Iluvien?) implant in a pseudophakic eye with intact posterior capsule

机译:玻璃体内氟喹啉酮丙酮酮(ILUVIENα)植入完整后胶囊的伪胶囊中植入物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PurposeTo describe a case of spontaneous anterior migration of intravitreal fluocinolone acetonide (Iluvien?) implant in a pseudophakic eye with intact posterior capsule.ObservationA 60-year old woman with proliferative diabetic retinopathy underwent uneventful pars plana vitrectomy and phacoemulsification with posterior chamber intraocular lens (PCIOL) implants in both eyes. She developed diabetic macular edema (DME) in her right eye which failed to respond to repeated intravitreal injections of Aflibercept 2mg/0.05ml (Eylea?). The patient received an intravitreal Iluvien? implant to treat the recalcitrant DME after she showed a favorable temporary response to dexamethasone intravitreal implant (Ozurdex?).Six months later she presented with pain in the right eye due to elevated intraocular pressure (IOP). The Iluvien? implant was found to be dislodged into the anterior chamber (AC) in the presence of an intact posterior capsule and stable PCIOL implant. The migrated Iluvien implant was removed and IOP was controlled with a glaucoma drainage valve as it failed to respond to maximum anti-glaucoma medication.Conclusions and ImportanceIntravitreal Iluvien? implant could migrate into the AC in a previously vitrectomized eyes in the presence of an intact posterior capsule.
机译:Purposeto描述了含有玻璃体内氟喹啉醇醋酸纤维素(ILUVIENα)的自发前迁移的案例,其植入于伪胶囊中,具有完整的后胶囊。具有增殖性糖尿病视网膜病变的不可切除的后囊囊肿,接受了平坦的平面玻璃体切除术和沉默乳化与后腔眼内透镜(PCiol )植入双眼。她在她的右眼开发了糖尿病黄斑水肿(DME),未来未能反应AFLiBercept 2mg / 0.05ml(eylea?)的重复玻璃体内注射。患者接受了含髂内髂内髂内的伊鲁维恩?植入治疗顽抗DME在表现出对地塞米松玻璃体植入物的有利临时反应(Ozurdex?)后。六个月后,由于眼压升高(IOP),她呈现出右眼的疼痛。 iluvien?发现植入物在完整的后胶囊和稳定的pciol植入物存在下脱落到前房(AC)中。移除了迁移的iluvien植入物,并用青光眼引流阀控制IOP,因为它未能应对最大的抗青光眼药物.Conclus和IntraptandtRaviteal Iluvien?植入物可以在完整的后胶囊存在下在先前玻璃化眼中迁移到AC中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号